Matthias J. Schnell

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups”.

Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups

Cell Reports(2020)10.1016/j.celrep.2020.107920

N/A

0DataRank · unranked

18 citations

David Lowe, Todd G. Smith, Yong Yang, Christina L. Hutson, Christoph Wirblich +3 more

Rhabdoviruses as vectors for vaccines and therapeutics

Current Opinion in Virology(2020)10.1016/j.coviro.2020.09.003

N/A

0DataRank · unranked

36 citations

Matthias J. Schnell, Gabrielle Scher

Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab014

N/A

0DataRank · unranked

27 citations

Christine R. Fisher, Gabrielle Scher, Catherine Yankowski, AnnaMarie Testa, Rohan Keshwara +8 more

Current vaccine strategies against SARS-CoV-2: Promises and challenges

Journal of Allergy and Clinical Immunology(2022)10.1016/j.jaci.2022.05.008

N/A

0DataRank · unranked

12 citations

Jacob Myers, Matthias J. Schnell, Drishya Kurup

A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model

Viruses(2022)10.3390/v14061126

N/A

0DataRank · unranked

6 citations

Christoph Wirblich, Leila Zabihi Diba, Rachael Lambert, Megan Watson, Noor Shaikh +4 more

GP38 as a Vaccine Target for Crimean-Congo Hemorrhagic Fever Virus

Research Square(2022)10.21203/rs.3.rs-1882445/v1

N/A

0DataRank · unranked

3 citations

Gabrielle Scher, Dennis A. Bente, Megan C. Mears, Maria N.B. Cajimat, Matthias J. Schnell

GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus

npj Vaccines(2023)10.1038/s41541-023-00663-5

N/A

0DataRank · unranked

27 citations

Dennis A. Bente, Megan C. Mears, Maria N.B. Cajimat, Matthias J. Schnell, Gabrielle Scher

Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge

npj Vaccines(2023)10.1038/s41541-023-00615-z

N/A

0DataRank · unranked

9 citations

Drishya Kurup, Christoph Wirblich, Matthias J. Schnell, Catherine Yankowski

Development of a Rabies Virus-Vectored Vaccine against Borrelia burgdorferi Targeting BBI39

The Medicine Forum(2023)10.20944/preprints202311.2009.v1

N/A

0DataRank · unranked

1 citations

Bibek Bhattachan, Kruthi Vavilikolanu, Chrysoula Kitsou, Utpal Pal, Matthias J. Schnell +1 more

An Inactivated Rabies-based Lassa Fever Virus Vaccine Candidate, LASSARAB, Protects Nonhuman Primates from Lethal Disease

Research Square(2023)10.21203/rs.3.rs-3673845/v1

N/A

0DataRank · unranked

0 citations

Gabrielle Scher, Catherine Yankowski, Drishya Kurup, Nicole Josleynl, Eric R. Wilkinson +8 more

Inactivated rabies-based Lassa fever virus vaccine candidate LASSARAB protects nonhuman primates from lethal disease

npj Vaccines(2024)10.1038/s41541-024-00930-z

N/A

0DataRank · unranked

17 citations

Catherine Yankowski, Drishya Kurup, Nicole Josleyn, Eric R. Wilkinson, Jay Wells +8 more

Immunogenicity of an adjuvanted, combination inactivated rabies-vectored, Lassa fever vaccine in healthy adults: interim results of a first-in-human Phase 1 trial

medRxiv(2025)10.1101/2025.10.16.25338178

N/A

0DataRank · unranked

0 citations

Drishya Kurup, A Kaufman, Sabrine Ben Hamed, Allison LaRocco, Kirsten E. Lyke +20 more